ArticleFrontiers in immunology2022

Case report: Eculizumab plus obinutuzumab induction in a deceased donor kidney transplant recipient with DEAP-HUS.

Evaldo Favi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.